CollabRx Inc. (NASDAQ:RNVA) posted its quarterly earnings data on Monday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.71.

Shares of CollabRx (NASDAQ:RNVA) opened at 0.143 on Monday. The firm’s 50-day moving average is $0.16 and its 200-day moving average is $0.39. CollabRx has a 1-year low of $0.11 and a 1-year high of $4.99. The stock’s market capitalization is $6.06 million.

Earnings History for CollabRx (NASDAQ:RNVA)

About CollabRx

Rennova Health, Inc (Rennova), formerly CollabRx, Inc, is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers.

5 Day Chart for NASDAQ:RNVA

Receive News & Stock Ratings for CollabRx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CollabRx Inc. and related stocks with our FREE daily email newsletter.